Drug Database
Back to search

France· FR:65070765

PRADAXA 20 mg, granulés enrobés

A dabigatran etexilate product containing mésilate de dabigatran étexilate, registered in France by BOEHRINGER INGELHEIM INTERNATIONAL. The same ATC class is registered in 16 of our 19 countries.

ATC B01AE07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPRADAXA 20 mg, granulés enrobésATCB01AE07REGISTER NO.FR:65070765PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mésilate de dabigatran étexilateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dabigatran etexilate is registered in 16 of 19 countries.

Countries holding a registration under ATC B01AE07 (dabigatran etexilate), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search dabigatran etexilate products by name

Dabigatran etexilate · ATC B01AE07

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dabigatran etexilate costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dabigatran etexilate · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.16
  • IT Italy$2.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MÉSILATE DE DABIGATRAN ÉTEXILATE
Manufacturer
BOEHRINGER INGELHEIM INTERNATIONAL
Country
France (FR)
ATC code
B01AE07
ATC class
Dabigatran etexilate
Defined daily dose
0.3 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930223918
    60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

47 interactions on record for dabigatran etexilate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dabigatran etexilate against other medicinesHow interaction checks work

Dabigatran etexilate · interactions on record

47 records

47 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Dabigatran etexilate in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dabigatran etexilate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Dabahib, Dabigatran Etexilaat Biocon
  • Belgium · Dabigatran Etexilaat Hcs, Dabigatran Etexilaat Liconsa
  • Bulgaria · Dabahib, Dabigatran Etexilate Laboratorios Liconsa
  • Cyprus · Dabigatran Etexilate Gedeon Richter, Dabigatran Etexilate Viatris
  • Czechia · Dabigatran Etexilát +pharma, Dabigatran Etexilate G.L. Pharma
  • Germany · Andabra, Dabigatran Beta
  • Denmark · Andabra, Dabigatran Etexilate "sandoz"
  • Estonia · Dabigatran Etexilate Stada, Dabigatran Etexilate Viatris
  • Spain · Andabra, Dabidose 150 Mg
  • Finland · Dabigatran Etexilate Gedeon Richter, Dabigatran Etexilate Glenmark
  • United Kingdom (Northern Ireland) · Dabigatran Etexilate Glenmark Pharmaceuticals Europe, Dabigatran Etexilate Sandoz
  • Greece · Andabra, Dabigatran Etexilate Ariti
  • Croatia · Dabigatraneteksilat Abela, Dabigatraneteksilat Gedeon Richter
  • Hungary · Dabigatran Etexilate Laboratorios Liconsa, Dabigatran Etexilate Sandoz
  • Ireland · Dabigatran Etexilate Clonmel Healthcare, Dabigatran Etexilate Gedeon Richter
  • Iceland · Dabigatran Etexilat Alembic, Dabigatran Etexilate Accord
  • Italy · Andabra, Auralgan
  • Liechtenstein · Dabigatran Etexilate Accord, Dabigatran Etexilate Teva
  • Lithuania · Dabigatran Etexilate Sandoz, Dabigatran Etexilate Stada
  • Luxembourg · Dabigatran Etexilate Eg, Dabigatran Etexilate Gedeon Richter
  • Latvia · Dabigatran Etexilate Sandoz, Dabigatran Etexilate Stada
  • Malta · Abagat, Auralgan
  • Netherlands · Dabigatran Etexilaat Alembic, Dabigatran Etexilaat Biocon
  • Norway · Dabigatran Accord, Dabigatran Etexilate Accord
  • Poland · Abagat, Dabigartan Sanexcel
  • Portugal · Dabigatran Azevedos, Dabigatran Etexilate Glenmark Arzneimittel Gmbh
  • Romania · Dabigatran Etexilat Dr. Reddy’s, Dabigatran Etexilat Gemax Pharma
  • Sweden · Dabigatran Etexilate G.L. Pharma, Dabigatran Etexilate Gedeon Richter
  • Slovenia · Dabigatraneteksilat Gedeon Richter, Dabigatraneteksilat Hcs
  • Slovakia · Dabahib, Dabigatran Etexilate Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aac9e1b8-0ccd-4241-9ed2-9811040dfff0
GET /v1/drugs/aac9e1b8-0ccd-4241-9ed2-9811040dfff0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65070765",
  "date_amm": "2021-01-11",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/08/442",
  "substance": "MÉSILATE DE DABIGATRAN ÉTEXILATE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "granulés enrobé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about dabigatran etexilate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console